Emerald Advisers’s Orthofix Medical OFIX Stock Holding History

Emerald Advisers’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$923	Hold	101	–	–	﹤0.01%	237
2026 Q1	$1.16K	Hold	101	–	–	﹤0.01%	248
2025 Q4	$1.53K	Hold	101	–	–	﹤0.01%	245
2025 Q3	$1.48K	Sell	101 -1	-1%	-$13	﹤0.01%	257
2025 Q2	$1.13K	Sell	102 -811,036	-100%	-$10M	﹤0.01%	247
2025 Q1	$13.2M	Sell	811,138 -11,239	-1%	-$197K	0.6%	69
2024 Q4	$14.4M	Buy	822,377 +89,717	+12%	+$1.56M	0.56%	71
2024 Q3	$11.4M	Sell	732,660 -1,339	-0.2%	-$21.5K	0.44%	81
2024 Q2	$9.73M	Sell	733,999 -31,205	-4%	-$428K	0.41%	86
2024 Q1	$11.1M	Buy	765,204 +8,018	+1%	+$111K	0.45%	92
2023 Q4	$10.2M	Buy	757,186 +195,704	+35%	+$2.3M	0.44%	93
2023 Q3	$7.22M	Sell	561,482 -133,873	-19%	-$2.41M	0.35%	101
2023 Q2	$12.6M	Buy	695,355 +201,962	+41%	+$3.77M	0.55%	82
2023 Q1	$8.26M	Buy	+493,393	New	+$9.66M	0.4%	95

Other funds holding OFIX

ECM

Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Emerald Advisers's OFIX Position: Q2 2026 in Review

Emerald Advisers held its Orthofix Medical (OFIX) position steady in Q2 2026 at 101 shares worth $923. The position accounts for ﹤0.01% of the portfolio, ranked #237.

Emerald Advisers first reported a position in OFIX in Q1 2023 and has held it in 14 quarters since. The position peaked at $14.4M in Q4 2024. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

Emerald Advisers held 101 shares of Orthofix Medical worth $923 as of Q2 2026.
Emerald Advisers left its Orthofix Medical share count unchanged in Q2 2026.
Orthofix Medical made up ﹤0.01% of Emerald Advisers's portfolio in Q2 2026, its #237 holding.
Emerald Advisers first reported a position in Orthofix Medical in Q1 2023 and has held it in 14 quarters since.
Emerald Advisers's Orthofix Medical position peaked at $14.4M in Q4 2024.
143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.